RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Cymbalta (drug) (INACTIVE)

A collection of news and information related to Cymbalta (drug) (INACTIVE) published by this site and its partners.

Top Cymbalta (drug) (INACTIVE) Articles see all

Displaying items 1-3
  • New therapies offer bright hope against the darkness of depression

     New therapies offer bright hope against the darkness of depression
    The numbers are staggering: Almost 7% of the U.S. adult population — about 17.6 million people — is diagnosed with depression, according to the National Institute of Mental Health. The national Centers for Disease Control and Prevention report that depression costs 200 million lost workdays each year at a cost to employers of $17 billion to $44 billion.
  • FDA approves a new antidepressant: Brintellix

    FDA approves a new antidepressant: Brintellix
    The Food and Drug Administration late Monday approved a new antidepressant medication that is a novel variant on the selective serotonin reuptake inhibitors, or SSRIs, that have become the mainstay of depression treatment. The drug, whose generic chemical...

    FDA panel gives a qualified nod to antidepressant for chronic pain

    As the advertisement for the antidepressant Cymbalta says, "Depression hurts. Cymbalta can help." Chronic pain hurts too. And the makers of the drug duloxetine -- commercially known as Cymbalta -- argue that Cymbalta can help with that, as well. Chronic...